Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden

被引:66
作者
Evengård, B [1 ]
Petersson, K
Engman, ML
Wiklund, S
Ivarsson, SA
Teär-Fahnehjelm, K
Forsgren, M
Gilbert, R
Malm, G
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Clin Bacteriol, Unit Parasitol, S-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Div Clin Bacteriol, Virol Unit, S-14186 Huddinge, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol & Pathol, S-14186 Huddinge, Sweden
[4] Huddinge Univ Hosp, Karolinska Inst, Dept Obstet & Gynaecol, S-14186 Huddinge, Sweden
[5] Huddinge Univ Hosp, Karolinska Inst, Dept Pediat, S-14186 Huddinge, Sweden
[6] Huddinge Univ Hosp, Karolinska Inst, Dept Ophthalmol, S-14186 Huddinge, Sweden
[7] Malmo Univ Hosp, Dept Pediat, Malmo, Sweden
[8] Inst Child Hlth, Dept Epidemiol & Biostat, London, England
关键词
D O I
10.1017/S0950268801005775
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To estimate the burden of disease due to congenital toxoplasmosis. in Sweden the incidence of primary infections during pregnancy and birth prevalence of congenital toxoplasmosis in 40978 children born in two regions in Sweden was determined. Women possibly infected during pregnancy were identified based on: 1, detection of specific IgG based on neonatal screening of the phenylketonuria (PKU) card blood spot followed by retrospective testing of stored prenatal samples to detect women who acquired infection during pregnancy and follow up of their children to 12 months; 2, detection of specific IgM on the PKU blood spot. The birth prevalence of congenital toxoplasmosis was 0.73/10 000 (95% CI 0.15-2.14) (3/40978). The incidence of primary infection during pregnancy was 5.1/10 000 (95 % CI 2.6-8.9) susceptible pregnant women. The seroprevalence in the southern part was 25.7 % and in the Stockholm area 14.0%. The incidence of infection during pregnancy was low, as the birth prevalence of congenital toxoplasmosis. Neonatal screening warrants consideration in view of the low cost and feasibility.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 32 条
[1]   MODELING AGE-SPECIFIC AND TIME-SPECIFIC INCIDENCE FROM SEROPREVALENCE - TOXOPLASMOSIS [J].
ADES, AE ;
NOKES, DJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) :1022-1034
[2]   INCIDENCE OF TOXOPLASMOSIS IN PREGNANT-WOMEN IN THE CITY OF MALMO, SWEDEN [J].
AHLFORS, K ;
BORJESON, M ;
HULDT, G ;
FORSBERG, E .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (03) :315-321
[3]  
AHLINAKERMAN B, 1980, GRIFFITHS UTVECKLING
[4]  
BORNAND JE, 1991, SCHWEIZ MED WSCHR, V121, P21
[5]   DIRECT AND SENSITIVE DETECTION OF A PATHOGENIC PROTOZOAN, TOXOPLASMA-GONDII, BY POLYMERASE CHAIN-REACTION [J].
BURG, JL ;
GROVER, CM ;
POULETTY, P ;
BOOTHROYD, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (08) :1787-1792
[6]   Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect Toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns [J].
Eaton, RB ;
Petersen, E ;
Seppanen, H ;
Tuuminen, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3147-3150
[7]  
Evengård B, 1999, SCAND J INFECT DIS, V31, P127, DOI 10.1080/003655499750006146
[8]  
FAHNEHJELM KT, OPHTHALMOLOGICAL FIN
[9]   TOXOPLASMA-GONDII ANTIBODIES IN PREGNANT-WOMEN IN STOCKHOLM IN 1969, 1979, AND 1987 [J].
FORSGREN, M ;
GILLE, E ;
LJUNGSTROM, I ;
NOKES, DJ .
LANCET, 1991, 337 (8754) :1413-1414
[10]   NEONATAL SEROLOGIC SCREENING AND EARLY TREATMENT FOR CONGENITAL TOXOPLASMA-GONDII INFECTION [J].
GUERINA, NG ;
HSU, HW ;
MEISSNER, HC ;
MAGUIRE, JH ;
LYNFIELD, R ;
STECHENBERG, B ;
ABROMS, I ;
PASTERNACK, MS ;
HOFF, R ;
EATON, RB ;
GRADY, GF ;
CHEESEMAN, SH ;
MCINTOSH, K ;
MEDEARIS, DN ;
ROBB, R ;
WEIBLEN, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (26) :1858-1863